Ozan Aricak

Artiklar

Article: ONCOIMMUNOLOGY. 2023;12(1):2233402
Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8⁺ T cells towards the center of human lung tumors
Brownlie D; von Kries A; Valenzano G; Wild N; Yilmaz E; Safholm J; Al-Ameri M; Alici E; Ljunggren H-G; Schliemann I; Aricak O; de Flon FH; Michaelsson J; Marquardt N
Article: ACTA ONCOLOGICA. 2023;62(12):1808-1814
Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals
Skribek M; Brunnstrom H; Oskarsdottir G; Grive MP; Aricak O; Planck M; Jatta K; Naserhojati H; de Flon FH; Ekman S
Article: ANNALS OF DIAGNOSTIC PATHOLOGY. 2021;51:151701
Clinicopathological significance of the expression of PD-L1 in non-small cell lung cancer
Montero MA; Aricak O; Kis L; Yoshikawa A; De Petris L; Grundberg O; Pham HHN; Roden AC; Fukuoka J; Attanoos R; Guijarro R; Alarcon F; Lindstrom K; Ortiz-Villalon C

Conference publication: ANNALS OF ONCOLOGY. 2022;33(7):S1087
Real-world insights into non-small cell lung cancer patients with MET exon 14 skipping mutations: A Swedish retrospective study from two university hospitals
Skribek M; Brunnstrom H; Aricak O; Planck M; Jatta K; Oskarsdottir GN; Naserhojati H; Haglund F; Ekman S